EphA2-siRNA was incorporated into liposomal nanoparticles (DOPC) called EPHARNA (EphA2-siRNA-DOPC) specifically targeting EphA2 expression in the epithelial mediated tumor [164,165,166]. This evidence concerns the gene EPHA2 and neoplasm.